Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 15Carcinoma, Non-Small-Cell Lung 5Breast Neoplasms 5Head and Neck Neoplasms 4Lung Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma, Ewing 2Rhabdomyosarcoma 2Neuroblastoma 2Adenocarcinoma 2Wilms Tumor 1Stomatitis 1Squamous Cell Cancer of Head and Neck (SCCHN) 1Skin Neoplasms 1Sarcoma, Clear Cell 1Sarcoma 1Rhabdoid Tumor 1Recurrence 1Radiation Injuries 1Prostate Cancer Metastatic 1Prostate Adenocarcinoma 1Pelvic Neoplasms 1Pancreatic Adenocarcinoma 1Osteosarcoma 1Oropharyngeal Neoplasms 1Neuroectodermal Tumors, Primitive 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1

Interventions

Oxaliplatin 32Fluorouracil 24Gemcitabine 23Leucovorin 19Docetaxel 19pembrolizumab 17Capecitabine 15Radiotherapy 14Irinotecan 13Cisplatin 11Bevacizumab 11Nivolumab 8130-nm albumin-bound paclitaxel 8Trastuzumab 7Erlotinib Hydrochloride 7Cyclophosphamide 7Albumin-Bound Paclitaxel 7Radiosurgery 6Paclitaxel 6Taxes 5S 1 (combination) 5Metformin 5Carboplatin 5Blood Specimen Collection 5Sunitinib 4Sorafenib 4Pemetrexed 4Esophagectomy 4Chemoradiotherapy 4Cetuximab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Adenocarcinoma × Radiotherapy, Image-Guided × Clear all
NCT07515651 2026-04-07

MIDAS-SBRT

University Health Network, Toronto

Phase 2 Not yet recruiting
50 enrolled
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT05328505 2026-03-24

MIDAS-Prostate

University Health Network, Toronto

Phase NA Recruiting
80 enrolled
Genitourinary

Adenocarcinoma, Prostatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡